Filed before 2025Filed 14 August 2024
Odyssey Therapeutics, Inc. has sold $117M so far
Odyssey Therapeutics, Inc., a biotech company based in Boston, MA, has sold $117M so far in its equity round, according to a filing dated 14 August 2024.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 14 August 2024
- First filed
- 15 December 2023
- Round
- Equity round (amended filing)
- Amount sold
- $117M
- Offering size
- $121M
- Investors so far
- 43
- Based in
- Boston, MA
- Website
- odysseytx.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 96% of the 1,434 tracked raises with an amount filed in 2024, and than 88% of the 138 in biotech.
Odyssey Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 4 Dec 2025 | New filing | $214M | Another raise |
| 14 Aug 2024 | Amended filing | $117M | This raise |
| 15 Dec 2023 | New filing | $97.1M | This raise |
More with Ascenta Capital on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.